A study to evaluate characteristics of EU patients initiating treatment with either Duavive or oestrogen + progestin hormone replacement therapy (E+P HRT) and Duavive utilization patterns
Latest Information Update: 09 Dec 2020
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary) ; Estradiol congener-compounds/progesterone congener compounds (Primary)
- Indications Atrophic vaginitis; Breast cancer; Postmenopausal osteoporosis; Vasomotor symptoms
- Focus Adverse reactions; Therapeutic Use
- 09 Dec 2020 New trial record